Literature DB >> 18834713

Administrative codes combined with medical records based criteria accurately identified bacterial infections among rheumatoid arthritis patients.

Nivedita M Patkar1, Jeffrey R Curtis, Gim Gee Teng, Jeroan J Allison, Michael Saag, Carolyn Martin, Kenneth G Saag.   

Abstract

OBJECTIVE: To evaluate diagnostic properties of International Classification of Diseases, Version 9 (ICD-9) diagnosis codes and infection criteria to identify bacterial infections among rheumatoid arthritis (RA) patients. STUDY DESIGN AND
SETTING: We performed a cross-sectional study of RA patients with and without ICD-9 codes for bacterial infections. Sixteen bacterial infection criteria were developed. Diagnostic properties of comprehensive and restrictive sets of ICD-9 codes and the infection criteria were tested against an adjudicated review of medical records.
RESULTS: Records on 162 RA patients with and 50 without purported bacterial infections were reviewed. Positive and negative predictive values of ICD-9 codes ranged from 54%-85% and 84%-100%, respectively. Positive predictive values of the medical records based criteria were 84% and 89% for "definite" and "definite or empirically treated" infections, respectively. Positive predictive value of infection criteria increased by 50% as disease prevalence increased using ICD-9 codes to enhance infection likelihood.
CONCLUSION: ICD-9 codes alone may misclassify bacterial infections in hospitalized RA patients. Misclassification varies with the specificity of the codes used and strength of evidence required to confirm infections. Combining ICD-9 codes with infection criteria identified infections with greatest accuracy. Novel infection criteria may limit the requirement to review medical records.

Entities:  

Mesh:

Year:  2008        PMID: 18834713      PMCID: PMC2736855          DOI: 10.1016/j.jclinepi.2008.06.006

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  53 in total

Review 1.  Infectious complications of treatment with biologic agents.

Authors:  Carol Dukes Hamilton
Journal:  Curr Opin Rheumatol       Date:  2004-07       Impact factor: 5.006

Review 2.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.

Authors:  Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay
Journal:  Crit Care Med       Date:  2003-04       Impact factor: 7.598

3.  Hepatic abscess: changes in clinical, bacteriologic and therapeutic aspects.

Authors:  R H Rubin; M N Swartz; R Malt
Journal:  Am J Med       Date:  1974-10       Impact factor: 4.965

Review 4.  Osteomyelitis: a review of clinical features, therapeutic considerations and unusual aspects.

Authors:  F A Waldvogel; G Medoff; M N Swartz
Journal:  N Engl J Med       Date:  1970-01-22       Impact factor: 91.245

5.  Infection in rheumatoid arthritis.

Authors:  J Baum
Journal:  Arthritis Rheum       Date:  1971 Jan-Feb

6.  Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent.

Authors:  J Keane; S Gershon; R P Wise; E Mirabile-Levens; J Kasznica; W D Schwieterman; J N Siegel; M M Braun
Journal:  N Engl J Med       Date:  2001-10-11       Impact factor: 91.245

Review 7.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.

Authors:  Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay
Journal:  Intensive Care Med       Date:  2003-03-28       Impact factor: 17.440

8.  Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention.

Authors:  Naomi P O'Grady; Mary Alexander; E Patchen Dellinger; Julie L Gerberding; Stephen O Heard; Dennis G Maki; Henry Masur; Rita D McCormick; Leonard A Mermel; Michele L Pearson; Issam I Raad; Adrienne Randolph; Robert A Weinstein
Journal:  MMWR Recomm Rep       Date:  2002-08-09

9.  Effect of verification bias on screening for prostate cancer by measurement of prostate-specific antigen.

Authors:  Rinaa S Punglia; Anthony V D'Amico; William J Catalona; Kimberly A Roehl; Karen M Kuntz
Journal:  N Engl J Med       Date:  2003-07-24       Impact factor: 91.245

10.  Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records.

Authors:  Yuka Kiyota; Sebastian Schneeweiss; Robert J Glynn; Carolyn C Cannuscio; Jerry Avorn; Daniel H Solomon
Journal:  Am Heart J       Date:  2004-07       Impact factor: 4.749

View more
  34 in total

1.  Brief Report: Intensification to Triple Therapy After Treatment With Nonbiologic Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis in the United States From 2009 to 2014.

Authors:  Jeffrey A Sparks; Alexis A Krumme; William H Shrank; Olga S Matlin; Gregory Brill; Edmund J Pezalla; Niteesh K Choudhry; Daniel H Solomon
Journal:  Arthritis Rheumatol       Date:  2016-07       Impact factor: 10.995

2.  A comparison of methods to detect urinary tract infections using electronic data.

Authors:  Timothy Landers; Mandar Apte; Sandra Hyman; Yoko Furuya; Sherry Glied; Elaine Larson
Journal:  Jt Comm J Qual Patient Saf       Date:  2010-09

3.  Risk of Hospitalized Infection and Initiation of Abatacept Versus Tumor Necrosis Factor Inhibitors Among Patients With Rheumatoid Arthritis: A Propensity Score-Matched Cohort Study.

Authors:  Sarah K Chen; Katherine P Liao; Jun Liu; Seoyoung C Kim
Journal:  Arthritis Care Res (Hoboken)       Date:  2019-11-29       Impact factor: 4.794

4.  A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registries.

Authors:  Jeffrey R Curtis; Archana Jain; Johan Askling; S Louis Bridges; Loreto Carmona; William Dixon; Axel Finckh; Kimme Hyrich; Jeffrey D Greenberg; Joel Kremer; Joachim Listing; Kaleb Michaud; Ted Mikuls; Nancy Shadick; Daniel H Solomon; Michael E Weinblatt; Fred Wolfe; Angela Zink
Journal:  Semin Arthritis Rheum       Date:  2010-08       Impact factor: 5.532

5.  Comparative Safety and Effectiveness of Denosumab Versus Zoledronic Acid in Patients With Osteoporosis: A Cohort Study.

Authors:  Nam-Kyong Choi; Daniel H Solomon; Theodore N Tsacogianis; Joan E Landon; Hong Ji Song; Seoyoung C Kim
Journal:  J Bone Miner Res       Date:  2017-02-07       Impact factor: 6.741

Review 6.  Databases and registers: useful tools for research, no studies.

Authors:  Rafael J Curbelo; Estíbaliz Loza; Maria Jesús García de Yébenes; Loreto Carmona
Journal:  Rheumatol Int       Date:  2014-02-08       Impact factor: 2.631

7.  Comparative Rates of Serious Infections Among Patients With Systemic Lupus Erythematosus Receiving Immunosuppressive Medications.

Authors:  Candace H Feldman; Francisco M Marty; Wolfgang C Winkelmayer; Hongshu Guan; Jessica M Franklin; Daniel H Solomon; Karen H Costenbader; Seoyoung C Kim
Journal:  Arthritis Rheumatol       Date:  2017-02       Impact factor: 10.995

8.  Initiation of tumor necrosis factor-α antagonists and the risk of hospitalization for infection in patients with autoimmune diseases.

Authors:  Carlos G Grijalva; Lang Chen; Elizabeth Delzell; John W Baddley; Timothy Beukelman; Kevin L Winthrop; Marie R Griffin; Lisa J Herrinton; Liyan Liu; Rita Ouellet-Hellstrom; Nivedita M Patkar; Daniel H Solomon; James D Lewis; Fenglong Xie; Kenneth G Saag; Jeffrey R Curtis
Journal:  JAMA       Date:  2011-11-06       Impact factor: 56.272

9.  Risk of hospitalised infection in rheumatoid arthritis patients receiving biologics following a previous infection while on treatment with anti-TNF therapy.

Authors:  Huifeng Yun; Fenglong Xie; Elizabeth Delzell; Lang Chen; Emily B Levitan; James D Lewis; Kenneth G Saag; Timothy Beukelman; Kevin Winthrop; John W Baddley; Jeffrey R Curtis
Journal:  Ann Rheum Dis       Date:  2014-03-07       Impact factor: 19.103

10.  A population-based study of infection-related hospital mortality in patients with dermatomyositis/polymyositis.

Authors:  Sara G Murray; Gabriela Schmajuk; Laura Trupin; Erica Lawson; Matthew Cascino; Jennifer Barton; Mary Margaretten; Patricia P Katz; Edward H Yelin; Jinoos Yazdany
Journal:  Arthritis Care Res (Hoboken)       Date:  2015-05       Impact factor: 4.794

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.